What is the Ownership and Shareholding Structure of Finebiotics Pharma?
In 2024, Finebiotics Pharma had a promoter holding of 79.87% and a public holding of 20.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX